DawnAFishbeinMD

Infectious Disease • Washington, DC

HIV/AIDS Medicine

Medical Director, DC Partnership for HIV/AIDS Progress Subspecialty Clinics

Join to view full profile

Dr. Fishbein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fishbein's full profile

Already have an account?

Office
110 Irving St Nw
Ste 2a56
Washington, DC 20010
Phone+1 202-877-7164

Fax+1 202-877-0341

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 2001 - 2004
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1998 - 2001
Albert Einstein College of MedicineClass of 1998

Certifications & Licensure

DC State Medical License 2009 - 2024
NY State Medical License 1999 - 2020
MD State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

27 citations
Hepatitis C patients’ self‐reported adherence to treatment with pegylated interferon and ribavirin
Jeffrey J. Weiss, Laveeza Bhatti, Douglas T. Dieterich, Brian R. Edlin, Dawn A. Fishbein
Alimentary Pharmacology & Therapeutics. 2008-08-01
243 citations
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
A. Osinusi, Eric G. Meissner, Yu-Jin Lee, Dimitra Bon, Laura Heytens
JAMA. 2013-08-28
17 citations
Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system.
Alexander G. Geboy, Whitney Nichols, Stephen Fernandez, Sameer Desale, Peter Basch
Plos One. 2019-05-23

Abstracts/Posters

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma
Dawn Fishbein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

Protective Immunity To HBV In HIV+ Patients With Isolated Hepatitis BNational Center For Research Resources2009
Protective Immunity To HBV In HIV+ Patients With Isolated HBV Core AntibodyNational Center For Research Resources2008
Pre-Chemotherapeutic Care Of HCV Infected Drug UsersNational Institute On Drug Abuse2004–2008